Native thrombopoietin: Structure and function

Stem Cells

Volumn 16, Issue 5, 1998, Pages 322-328

  Kato, Takashi ^a   Matsumoto, Atsushi ^a   Ogami, Kinya ^a   Tahara, Tomoyuki ^a   Morita, Haruhiko ^a   Miyazaki, Hiroshi ^a  

^a KIRIN BREWERY CO LTD   (Japan)

Author keywords

ELISA; Native thrombopoietin; Posttranslational processing; Proteolysis; Thrombocytopenia; Thrombopoietin; Truncation

Indexed keywords

THROMBOPOIETIN;

ARTICLE; BONE MARROW; GENE EXPRESSION; HEMATOPOIESIS; HUMAN; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NONHUMAN; PROTEIN STRUCTURE; RAT; THROMBOCYTOPENIA;

ANIMALIA;

EID: 0031691754     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.160322     Document Type: Article

References (70)

1. Kaushansky K, Lok S, Holly RD et al. Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin. Nature 1994;369:568-571.
2. Wendung F, Maraskovsky E, Debili N et al. cMpl ligand is a humoral regulator of megakaryocytopoiesis. Nature 1994;369:571-574.
3. Kuter DJ, Beeler DL, Rosenberg RD. The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci USA 1994;91:11104-11108.
4. Kato T, Ogami K, Shimada Y et al. Purification and characterization of thrombopoietin. J Biochem 1995;118:229-236. Published erratum 119:208.
5. de Sauvage FJ, Hass PE, Spencer SD et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature 1994;369:533-538.
6. Hunt P, Li L, Nichol JL et al. Purification and biological characterization of plasma-derived megakaryocyte growth and development factor (MGDF). Blood 1995;86:540-547.
7. Lok S, Kaushansky K, Holly RD et al. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo. Nature 1994;369:565-568.
8. Bartley TD, Bogenberger J, Hunt P et al. Identification and cloning of a megakaryocyte growth and development factor that is a ligand for the cytokine receptor Mpl. Cell 1994;77:1117-1124.
9. Sohma Y, Akahori H, Seki N et al. Molecular cloning and chromosomal localization of the human thrombopoietin gene. FEBS Lett 1994;353:57-61.
10. Ogami K, Shimada Y, Sohma Y et al. The sequence of a rat cDNA encoding thrombopoietin. Gene 1995;158:309-310.
11. Kaushansky K. Thrombopoietin: the primary regulator of platelet production. Blood 1995;86:419-431.
12. Miyazaki H, Inoue H, Yanagida M et al. Purification of rat megakaryocyte colony-forming cells using a monoclonal antibody against rat platelet glycoprotein IIb/IIIa. Exp Hematol 1992;20:855-861.
13. Miyazaki H, Horie K, Shimada Y. A simple and quantitative liquid culture system to measure megakaryocyte growth using highly purified CFU-MK. Exp Hematol 1995;23:1224-1228.
14. + subpopulation of rat megakaryocyte progenitor cells exhibits high responsiveness to human thrombopoietin. Exp Hematol 1996;24:1209-1214.
15. Debili N, Wendling F, Katz A et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 1995;86:2516-2525.
16. Kaushansky K, Broudy VC, Lin N et al. Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development. Proc Natl Acad Sci USA 1995;92:3234-3238.
17. Zucker-Franklin D, Kaushansky K. Effect of thrombopoietin on the development of megakaryocytes and platelets: an ultrastructural analysis. Blood 1996;88:1632-1638.
18. Choi ES, Hokom MM, Chen JL et al. The role of megakaryocyte growth and development factor in terminal stages of thrombopoiesis. Br J Haematol 1996;95:227-233.
19. Horie K, Miyazaki H, Hagiwara T et al. Action of thrombopoietin at the megakaryocyte progenitor level is critical for the subsequent proplatelet production. Exp Hematol 1997;25:169-176.
20. Kobayashi M, Laver JH, Kato T et al. Recombinant human thrombopoietin (Mpl ligand) enhances proliferation of erythroid progenitors. Blood 1995;86:2494-2499.
21. Era T, Takahashi T, Sakai K et al. Thrombopoietin enhances proliferation and differentiation of murine yolk sac erythroid progenitors. Blood 1997;89:1207-1213.
22. Kieran MW, Perkins AC, Orkin SH et al. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci USA 1996;93:9126-9131.
23. Alexander WS, Roberts AW, Nicola NA et al. Deficiencies in progenitor cells of multiple hematopoietic lineages and defective megakaryocytopoiesis in mice lacking the thrombopoietic receptor c-Mpl. Blood 1996;87:2162-2170.
24. Carver-Moore K, Broxmeyer HE, Luoh SM et al. Low levels of erythroid and myeloid progenitors in thrombopoietin- and c-mpl-deficient mice. Blood 1996;88:803-808.
25. Ku H, Yonemura Y, Kaushansky K et al. Thrombopoietin, the ligand for the Mpl receptor, synergizes with steel factor and other early acting cytokines in supporting proliferation of primitive hematopoietic progenitors of mice. Blood 1996;87:4544-4551.
26. Sitnicka E, Lin N, Priestley GV et al. The effect of thrombopoietin on the proliferation and differentiation of murine hematopoietic stem cells. Blood 1996;87:4998-5005.
27. Itoh R, Katayama N, Kato T et al. Activity of the ligand for c-mpl, thrombopoietin, in early haemopoiesis. Br J Haematol 1996;94:228-235.
28. Kobayashi M, Laver JH, Kato T et al. Thrombopoietin supports proliferation of human primitive hematopoietic cells in synergy with Steel factor and/or interleukin-3. Blood 1996;88:429-436.
29. -) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med 1996;183:2551-2558.
30. Tanimukai S, Kimura T, Sakabe H et al. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro. Exp Hematol 1997;25:1025-1033.
31. Kaushansky K, Lin N, Grossmann A et al. Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice. Exp Hematol 1996;24:265-269.
32. Grossmann A, Lenox J, Ren H et al. Thrombopoietin accelerates platelet, red blood cell, and neutrophil recovery in myelosuppressed mice. Exp Hematol 1996;24:1238-1246.
33. Akahori H, Shibuya K, Ozai M et al. Effects of pegylated recombinant human megakaryocyte growth and development factor on thrombocytopenia induced by a new myelosuppressive chemotherapy regimen in mice. STEM CELLS 1996;14:678-689.
34. Farese AM, Hunt P, Grab LB et al. Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia. J Clin Invest 1996;97:2145-2151.
35. Shibuya K, Akahori H, Takahashi K et al. Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice. Blood 1998;91:37-45.
36. Chang MS, McNinch J, Basu RJ et al. Cloning and characterization of the human megakaryocyte growth and development factor (MGDF) gene. J Biol Chem 1995;270:511-514.
37. Gurney AL, Kuang WJ, Xie MH et al. Genomic structure, chromosomal localization, and conserved alternative splice forms of thrombopoietin. Blood 1995;85:981-988.
38. Stoffel R, Wiestner A, Skoda RC. Thrombopoietin in thrombocytopenic mice: evidence against regulation at the mRNA level and for a direct regulatory role of platelets. Blood 1996;87:567-573.
39. Hoshi S, Yoshitomi H, Komatsu N et al. Megakaryocytopoietic activity of a truncated variant of mouse thrombopoietin. Biochem Biophys Res Commun 1997;231:823-826.
40. Shimada T, Kato T, Ogami K et al. Production of thrombopoietin (TPO) by rat hepatocytes and hepatoma cell lines. Exp Hematol 1995;23:1388-1396.
41. Nomura S, Ogami K, Kawamura K et al. Cellular localization of thrombopoietin mRNA in the liver by in situ hybridization. Exp Hematol 1997;25:565-572.
42. Shimodaira S, Ishida F, Ichikawa N et al. Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis. Thromb Haemost 1996; 76:545-548.
43. Ulich TR, del Castillo J, Yin S et al. Megakaryocyte growth and development factor ameliorates carboplatin-induced thrombocytopenia in mice. Blood 1995;86:971-976.
44. Cohen-Solal K, Villeval JL, Titeux M et al. Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 1996;88:2578-2584.
45. McCarty JM, Sprugel KH, Fox NE et al. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 1995;86:3668-3675.
46. Sungaran R, Markovic B, Chong BH. Localization and regulation of thrombopoietin mRNA expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 1997;89:101-107.
47. Ogami K. Gene expression and transcriptional regulation of thrombopoietin. STEM CELLS 1996; 14(suppl 1):148-153
48. Kamura T, Handa H, Hamasaki N et al. Characterization of the human thrombopoietin gene promoter. A possible role of an Ets transcription factor, E4TF1/GABP. J Biol Chem 1997;272:11361-11368.
49. Foster DC, Sprecher CA, Grant FJ et al. Human thrombopoietin: gene structure, cDNA sequence, expression, and chromosomal localization. Proc Natl Acad Sci USA 1994;91:13023-13027.
50. Bouscary D, Fontenay-Roupie M, Chretien S et al. Thrombopoietin is not responsible for the thrombocytosis observed in patients with acute myeloid leukemias and the 3q21q26 syndrome. Br J Haematol 1995;91:425-427.
51. Suzukawa K, Satoh H, Taniwaki M et al. The human thrombopoietin gene is located on chromosome 3q26.33-q27, but is not transcriptionally activated in leukemia cells with 3q21 and 3q26 abnormalities (3q21q26 syndrome). Leukemia 1995;9:1328-1331.
52. Schnittger S, de Sauvage FJ, Le Paslier D et al. Refined chromosomal localization of the human thrombopoietin gene to 3q27-q28 and exclusion as the responsible gene for thrombocytosis in patients with rearrangements of 3q21 and 3q26. Leukemia 1996;10:1891-1896.
53. Kondo T, Okabe M, Sanada M et al. Identification of TPO gene mutation in familial essential thrombocythemia. Blood 1997;90(suppl):54a.
54. Wiestner A, Schlemper RJ, van der Maas AP et al. An activating splice donor mutation in the thrombopoietin gene causes hereditary thrombocythaemia. Nat Genet 1998;18:49-52.
55. Kunishima S, Mizuno S, Naoe T et at. Genes for thrombopoietin and c-mpl are not responsible for familial thrombocythaemia: a case study. Br J Haematol 1998;100:383-386.
56. Kato T. Protein characteristics of thrombopoietin. STEM CELLS 1996;14(suppl 1):139-147.
57. Foster D, Lok S. Biological roles for the second domain of thrombopoietin. STEM CELLS 1996;14(suppl 1):102-107.
58. Wada T, Nagata Y, Nagahisa H et al. Characterization of the truncated thrombopoietin variants. Biochem Biophys Res Commun 1995;213:1091-1098.
59. Kato T, Oda A, Inagaki Y et al. Thrombin cleaves recombinant human thrombopoietin: one of the proteolytic events that generates truncated forms of thrombopoietin. Proc Natl Acad Sci USA 1997;94:4669-4674.
60. Linden H, Kaushansky K. The glycan domain of thrombopoietin enhances secretion. Blood 1997;90(suppl):55a.
61. Li B, Dai W. Thrombopoietin and neurotrophins share a common domain. Blood 1995;86:1643-1644.
62. Pearce KH Jr, Potts BJ, Presta LG et al. Mutational analysis of thrombopoietin for identification of receptor and neutralizing antibody sites. J Biol Chem 1997;272:20595-20602.
63. Tahara T, Kuwaki T, Matsumoto A et al. Neutralization of biological activity and inhibition of receptor binding by antibody against human thrombopoietin. STEM CELLS 1998;16:54-60.
64. Park H, Park SS, Jin EH et al. Identification of functionally important residues of human thrombopoietin. J Biol Chem 1998;273:256-261.
65. Tahara T, Usuki K, Sato H et al. A sensitive sandwich ELISA for measuring thrombopoietin in human serum: serum thrombopoietin levels in healthy volunteers and in patients with haemopoietic disorders. Br J Haematol 1996;93:783-788.
66. Kuter DJ, Rosenberg RD. The reciprocal relationship of thrombopoietin (c-Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 1995;85:2720-2730.
67. Kuter DJ, Miyazaki H, Kato T. The purification of thrombopoietin from thrombocytopenic plasma. In: Kuter DJ, Sheridan WP, Hunt P et al., eds. Thrombopoiesis and Thrombopoietins: Molecular, Cellular, Preclinical, and Clinical Biology. New Jersey: Humana Press, 1996:143-164.
68. 246. Biochemistry 1996;35:14849-14861.
69. Matsumoto A, Tahara T, Monta H et al. The native human thrombopoietin in blood: some properties of the endogenous thrombopoietin of the normal and patients with hematopoietic disorders. Blood 1996;88(suppl):544a.
70. Fielder PJ, Hass P, Nagel M et al. Human platelets as a model for the binding and degradation of thrombopoietin. Blood 1997;89:2782-2788.